Press "Enter" to skip to content

Israel Isolates Key Corornavirus Antibody at IIBR

Israel has isolated a crucial coronavirus antibody at its main biological analysis laboratory, the Israeli defense minister stated Monday, calling the step a vital breakthrough toward a possible treatment for the COVID-19 pandemic.

Israel Isolates Key Corornavirus Antibody at IIBR

The monoclonal neutralizing antibody developed at the Israel Institute for Biological Research (IIBR) can neutralize it (the disease-causing coronavirus) inside carriers’ our bodies, Defence Minister Naftali Bennett mentioned in a statement.

The assertion added that Bennett visited the IIBR on Monday, where he was briefed on a significant breakthrough find an antidote for the coronavirus”.

It quoted IIBR Director Shmuel Shapira as saying that the antibody system was being patented, after which a world manufacturer would be sought to mass-produce it.

The IIBR has been the main Israeli efforts to develop a remedy and vaccine for the coronavirus, including the testing of blood from those who recovered from COVID-19, the respiratory illness attributable to the coronavirus.

Antibodies in such samples – immune-system proteins that are residues of successfully overcoming the coronavirus – are broadly seen as crucial to developing a possible cure.

The antibody reported as having been isolated at the IIBR is monoclonal, which means it was derived from a single recovered cell and is thus potentially of stronger value in yielding a remedy.

Elsewhere, there have been coronavirus remedies developed from antibodies that are polyclonal or derived from two or extra cells of different ancestry, the journal Science Direct featured in its May issue.

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *